Menu

Latest Insights

PTAB Upholds Acorda’s Ampyra® Patents, Rejecting Challenges Based on the Inventors’ Own Work media type
October 31, 2017

Federal Circuit’s Braintree Opinion Reverses Finding of No Inducement in View of Generic Drug Product Label media type
October 31, 2017

Five Takeaways from Combination Drug Treatment and Dissolution Range Patent Rulings in Orexigen v. Actavis media type
October 09, 2017

Aqua Products, Inc. v. Matal: Petitioners Bear the Burden of Establishing the Unpatentability of Amended Claims in IPR Proceedings media type
October 09, 2017

Against the Backdrop of a ‘National Emergency,’ Are Opioid Cos. Ready for the Enforcement Spotlight? media type
September 06, 2017

New Guidance from the High Court on the Ability of Trustees to Pay Noteholder Expenses media type
August 29, 2017

This Week in Washington for August 28, 2017 media type
August 28, 2017

Against the Backdrop of a ‘National Emergency,’ Are Opioid Manufacturers Ready for the Enforcement Spotlight? media type
August 25, 2017

Visual Memory LLC v. NVIDIA Corp.: Panel-dependency for § 101 Challenges at the 12(b)(6) Stage media type
August 23, 2017

This Week in Washington for August 21, 2017 media type
August 21, 2017

Pages: 1 2 3 4 5 Next > Show All

Spotlight

Paul Hastings Blogs
Sign Up
Paul Hastings - Breaking the Glass Ceiling